Publications by authors named "How Cheng Low"

Claim this Profile
S
Sedation by non-anaesthesiologists in gastrointestinal endoscopy.
Andrew Ming Liang Ong, How Cheng Low, Christopher Tze Wei Chia

Ann Acad Med Singap· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying Patients With Cirrhosis Who Might Avoid Screening Endoscopy Based on Serum Albumin and Bilirubin and Platelet Counts.
Guan Sen Kew, Zhao Jin Chen, Alexander Wenjun Yip, Yu Wei Cheryl Huang, Li Yin Tan, How Cheng Low

Clin Gastroenterol Hepatol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A low-cost endoscopy trainer for novice endoscopy training in COVID-19.
Chieh Sian Koo, Kewin Tien Ho Siah, How Cheng Low, Calvin Jianyi Koh

Endoscopy· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for ribavirin treatment failure in Asian organ transplant recipients with chronic hepatitis E infection.
En Xian Sarah Low, Edhel Tripon, Kieron Lim, Poh Seng Tan, How Cheng Low

World J Hepatol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute-on-chronic liver failure in a multi-ethnic Asian city: A comparison of patients identified by Asia-Pacific Association for the Study of the Liver and European Association for the Study of the Liver definitions.
Anandraj Selva Rajoo, Seng-Gee Lim, Wah Wah Phyo, Thandar Tun, Yock-Young Dan, How-Cheng Low

World J Hepatol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreatic gout and the role of multimodality imaging in its management.
Huiliang Koh, How Cheng Low, Ju Ee Seet, Wynne Yuru Chua

BMJ Case Rep· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver disease progression and virological response: entecavir rescue still possible in the setting of rtM204I lamivudine-resistant mutation.
Poh Seng Tan, Myat Oo Aung, Yock Young Dan, Yin Mei Lee, Kieron Lim, How Cheng Low

Gut· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do different lamivudine-resistant hepatitis B genotypes carry the same risk of entecavir resistance?
Guan Huei Lee, Myat Oo Aung, Yock Young Dan, Yin Mei Lee, Belinda Mak, How Cheng Low

J Med Virol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis: a pilot study.
Yin-Mei Lee, How Cheng Low, Lee Guan Lim, Yock Young Dan, Myat Oo Aung

Gastrointest Endosc· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of lamivudine-adefovir therapy in chronic hepatitis B cirrhosis.
Seng Gee Lim, Myat Oo Aung, Belinda Mak, Dede Sutedja, Yin Mei Lee, How Cheng Low

J Clin Gastroenterol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of new legislation on presumed consent on organ donation on liver transplant in Singapore: a preliminary analysis.
How-Cheng Low, Maureen Da Costa, Krishnan Prabhakaran, Manjit Kaur, Aileen Wee

Transplantation· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis